Get started

Chemicalstock

Huntsman Corporation | HUN | Long at $11.34The stock price for Huntsman Corp NYSE:HUN , a manufacturer of organic chemical products, has dropped significantly since its peak in 2022 ($41.65). This was due to lower sales volumes, weak demand in construction and transportation, higher input costs, and European operational challenges, including a $75M hit from closing a German Maleic Anhydride facility. This year (2025) is anticipated to be its worst earnings year, and the stock is priced as such. However, this stock is historically cyclical, and the company expects recovery / growth again in 2026. Moving forward, earnings are forecast to grow and the company is trading at good value compared to peers and the industry. While many headwinds may still exist with tariffs, etc., insider are grabbing shares and large options positions (very bullish). With a book value of $17, debt-to-equity at 0.8x, quick ratio under 1, etc., the company appears healthy. From a technical analysis perspective, the stock price just barely missed my "crash" simple moving average area (currently between $9.00 and $10.50). It may reach those levels and below in 2025, for which I will add another position as long as fundamentals do not change. This moving average area often signifies "bottom" territory and historically, the stock has rebounded from this area. While my entry at $11.34 may be a little early, predicting true bottoms isn't my trading method and I hope to strengthen the position at lower trading prices. Targets: $15.00 (+32.2%) $17.25 (+49.9%)
NYSE:HUNLong
by WorthlessViews
Olin Corporation | OLIN | Long at $21.81Olin Corp NYSE:OLN is currently trading within my "crash" simple moving average area (green lines on the chart). Historically, the price trades within this area for the company, consolidates, and then moves up. After today's earnings, which were relatively positive, the stock may gain some traction and move up. However, I am cautious a media-heightened economic downturn could send NYSE:OLN (a global manufacturer of chemical products and ammunition) to $13 to close the existing price gaps on the daily chart. Regardless, it's a strong company that has been trading on the US stock exchange since the mid-1970s - it's seen rough times before. While 2025 is likely to be a tough year, future earnings projections predict robust earnings growth. Time will tell... Thus, at $21.81, NYSE:OLN is in a personal buy-zone with noted caution if there is an economic downturn down to $13 a share. The price gap around $19 may also be closed in the near-term. Targets into 2028: $28.00 (+28.4%) $31.50 (+44.4%)
NYSE:OLNLong
by WorthlessViews
Linde: The $300 Billion Market Cap Journey Starts HereLinde plc stands as the undisputed global titan in industrial gases and engineering playing a critical role in high-growth sectors such as semiconductor manufacturing green hydrogen infrastructure and healthcare services where its long-term contract structure and ability to pass through energy costs provide an exceptional competitive moat the current weekly chart reveals a definitive breakout from a multi-year consolidation range between 380 and 460 dollars which has effectively transitioned the stock into a price discovery phase with no overhead resistance the technical indicators reinforce this bullish outlook as the upward momentum on the weekly timeframe is accelerating sharply above the key moving averages while the relative strength histogram shows a steady increase in buyer conviction following the successful flip of the 460 dollar level from resistance to support looking ahead toward a target of 600 dollars and beyond the move is fundamentally supported by a record project backlog exceeding 8 billion dollars and a strategic pivot toward the hydrogen economy which justifies a premium valuation multiple compared to traditional chemical peers a climb toward a 300 billion dollar market capitalization would mathematically place the share price near the 647 dollar mark representing a significant but achievable extension of the current trend if the company continues to deliver on its projected earnings growth of 8 to 10 percent annually while maintaining its aggressive share buyback program the path of least resistance remains upward as long as the 460 dollar support zone holds on a closing basis making this a premier setup for investors seeking a combination of defensive stability and structural growth potential within the materials and energy transition space
NASDAQ:LINLong
by PEKBIT
Orion S.A.| OEC | Long at $5.75Orion NYSE:OEC : Another chemicals company in the dumps, but is it justified - long-term? Technical Analysis Price fell through my "crash" simple moving average zone (green lines). The last time this happened the price moved down to my "major crash" zone (gray lines) and subsequently rallied to a 4x investment 1.5 years later. Not to say that same trajectory will happen, but this company (like all chemical companies) are historically cyclical. The price may continue to drop into the $3's in the near-term and complete the "major crash" touch, but a longer-term outlook is likely to generate positive returns... likely... Growth A bad 2025, but beyond that, projections show growth in earnings and revenue through 2027: www.tradingview.com Fair Value and Health Fair value: $8.30 Tangible Fair Value: $6.58 Company cut its 2025 guidance due to softer demand and shifted focus to free cash flow generation. Debt-to-equity: 2.19x (high) Action While this is mostly a technical analysis play, there are so many opportunities right now with chemical companies. The tape beyond 2025 is likely to be positive and those who can stomach the near-term risks (i.e. $3's) may do well long-term. But there are better plays out there for the impatient. Targets into 2028 $6.60 (+14.8%) $9.00 (+56.5%)
NYSE:OECLong
by WorthlessViews
Celanese Corp | CE | Long at $39.64Celanese Corp is another chemical company (like Dow Inc) crushed by tariffs and economic headwinds. It's dropped -78% in one year.... However, this is a very strong company with strong credit market interest and no immediate liquidity crisis. From a technical analysis perspective, this... like in 2008 and 2020... is the time to gather shares given it has reached the "abysmal crash" levels based on my selected simple moving averages. In the past, recovery to new highs has taken 1-2 years. History doesn't always repeat, but fear is opportunity in the stock market. If negative news continues to reign, a dip into the high $20's isn't out of the question. If the company can squeak through 2025 and not continue to stack debt (debt/equity=2.43x), the growth opportunity into 2027-2028 looks promising. I'm keeping my targets into 2026 low, but this could be a good buy and hold for the right investor. Targets: $47.00 $54.75
NYSE:CELong
by WorthlessViews
Dow Inc.: Low in PlaceDow Inc. managed to hold and respond well within our active Target Zone(s) between $35.93 and $22.83 at the relevant Fibonacci levels. We currently assume that wave (II) in blue has been successfully completed, which leads us to anticipate a rise above the two indicated resistance levels ($55.67 and $71.86). Our zones remain active and could still be used for entering long positions. However, it should be noted that the price range could be tested further, and a completely new low is even possible under our alternative scenario: this wave count outlines a significantly stronger setback with the blue wave alt.(II), which would mean breaking through our dark green-blue Target Zones (probability: 35%).
NYSE:DOW
by HKCM_Global
1
daily chart analysis for SUMICHEMStock analysis for SUMITOMO CHEMICAL IND LTD keep watching add to watch list price falling each time when touches to upper trend line with conforming signal by RSI falling when it touch to 70 again price is testing upper trend line and RSI at 70 from here we can expect down side move in stock to lower trend line if price successfully closes above upper trend line then it may go more up side if price breakdown the lower trend line then rsi trend line will also break then will consider it more fresh selling and fall in price
NSE:SUMICHEM
by RA_Dongre_Ji
BASF this is what I expect from such a companyMy advisor Marketmiracle generated a purchase signal on BASF at a price of 69.16 with a target price of 72.95 or with a potential profit of 5.48% Effectively the last business results have been beyond the expectations and from the diagram it is clear as the title, after to have tried a sudden climb of fact has been collided with of the technical resistances that have rejected it. Now seems back the time of collection and, considering also the market sentiment that has returned slightly positive (0.02) we should start to see an increase in prices definitely up to the price of 72.95 indicated by the advisor but perhaps even beyond. It might therefore be interesting to start taking positions on BASF and then assess whether to close at that level or let go of positions for a more consistent climb. This idea is based on a signal generated by the advisor Marketmiracle, down on this page you will find the link to the page of signals of the advisor that you can see for free without any cost or registration
XETR:BASLong
by MarketMiracleAdvisor